Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.
Future Oncol
; 14(5): 417-430, 2018 Feb.
Article
in En
| MEDLINE
| ID: mdl-29094609
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Esophageal Neoplasms
/
Adenocarcinoma
/
Esophagogastric Junction
/
Molecular Targeted Therapy
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents, Immunological
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Future Oncol
Year:
2018
Type:
Article
Affiliation country:
United States